Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
18 | 4 | CHEMISTRY, ANALYTICAL//TOXICOLOGY//ENVIRONMENTAL SCIENCES | 697102 |
305 | 3 | NSAIDS//TOXIC EPIDERMAL NECROLYSIS//NON STEROIDAL ANTI INFLAMMATORY DRUGS | 41294 |
923 | 2 | CYCLOOXYGENASE 2//COX 2//CYCLOOXYGENASE | 11303 |
10809 | 1 | CRTH2//PROSTAGLANDIN D 2//MOL BEHAV BIOL | 1061 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CRTH2 | authKW | 1855992 | 8% | 77% | 81 |
2 | PROSTAGLANDIN D 2 | authKW | 1631660 | 14% | 38% | 146 |
3 | MOL BEHAV BIOL | address | 1579665 | 11% | 46% | 116 |
4 | PGD2 | authKW | 649170 | 5% | 43% | 51 |
5 | PROSTAGLANDIN D SYNTHASE | authKW | 611008 | 3% | 57% | 36 |
6 | DP RECEPTOR | authKW | 561171 | 2% | 82% | 23 |
7 | LIPOCALIN TYPE PROSTAGLANDIN D SYNTHASE | authKW | 542671 | 2% | 70% | 26 |
8 | CRTH2 ANTAGONIST | authKW | 437441 | 2% | 82% | 18 |
9 | BETA TRACE | authKW | 412408 | 2% | 73% | 19 |
10 | DP2 | authKW | 278873 | 1% | 72% | 13 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Allergy | 1573 | 6% | 0% | 62 |
2 | Chemistry, Medicinal | 1019 | 10% | 0% | 104 |
3 | Biochemistry & Molecular Biology | 984 | 28% | 0% | 297 |
4 | Pharmacology & Pharmacy | 915 | 19% | 0% | 202 |
5 | Immunology | 701 | 14% | 0% | 146 |
6 | Neurosciences | 295 | 12% | 0% | 128 |
7 | Cell Biology | 239 | 10% | 0% | 102 |
8 | Endocrinology & Metabolism | 201 | 7% | 0% | 69 |
9 | Biophysics | 158 | 5% | 0% | 58 |
10 | Respiratory System | 112 | 3% | 0% | 35 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOL BEHAV BIOL | 1579665 | 11% | 46% | 116 |
2 | ADV MED DEV | 166321 | 1% | 40% | 14 |
3 | HUMAN GENE SCI | 166071 | 2% | 23% | 24 |
4 | OSAKA BIOSCI | 62893 | 1% | 35% | 6 |
5 | CLIN DEV MED AFFAIRS THER EUT AREA P DIS | 59407 | 0% | 100% | 2 |
6 | ANIM RADIOL | 59399 | 1% | 33% | 6 |
7 | MENTAL HLTH ENVIRONM EFFECTS | 47520 | 0% | 40% | 4 |
8 | HAYAISHI BIOINFORMAT TRANSFER PROJECT | 39603 | 0% | 67% | 2 |
9 | ABENO KU MED | 29703 | 0% | 100% | 1 |
10 | ANTIBACT IMMUNOL CANC | 29703 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 14971 | 3% | 2% | 31 |
2 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 3731 | 1% | 1% | 10 |
3 | PROSTAGLANDINS | 3067 | 1% | 1% | 12 |
4 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2696 | 2% | 1% | 17 |
5 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2270 | 4% | 0% | 45 |
6 | EXPERT OPINION ON THERAPEUTIC PATENTS | 1038 | 1% | 0% | 9 |
7 | JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING | 959 | 0% | 1% | 3 |
8 | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 860 | 2% | 0% | 18 |
9 | BRITISH JOURNAL OF PHARMACOLOGY | 767 | 2% | 0% | 22 |
10 | CLINICAL AND EXPERIMENTAL ALLERGY | 680 | 1% | 0% | 11 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CRTH2 | 1855992 | 8% | 77% | 81 | Search CRTH2 | Search CRTH2 |
2 | PROSTAGLANDIN D 2 | 1631660 | 14% | 38% | 146 | Search PROSTAGLANDIN+D+2 | Search PROSTAGLANDIN+D+2 |
3 | PGD2 | 649170 | 5% | 43% | 51 | Search PGD2 | Search PGD2 |
4 | PROSTAGLANDIN D SYNTHASE | 611008 | 3% | 57% | 36 | Search PROSTAGLANDIN+D+SYNTHASE | Search PROSTAGLANDIN+D+SYNTHASE |
5 | DP RECEPTOR | 561171 | 2% | 82% | 23 | Search DP+RECEPTOR | Search DP+RECEPTOR |
6 | LIPOCALIN TYPE PROSTAGLANDIN D SYNTHASE | 542671 | 2% | 70% | 26 | Search LIPOCALIN+TYPE+PROSTAGLANDIN+D+SYNTHASE | Search LIPOCALIN+TYPE+PROSTAGLANDIN+D+SYNTHASE |
7 | CRTH2 ANTAGONIST | 437441 | 2% | 82% | 18 | Search CRTH2+ANTAGONIST | Search CRTH2+ANTAGONIST |
8 | BETA TRACE | 412408 | 2% | 73% | 19 | Search BETA+TRACE | Search BETA+TRACE |
9 | DP2 | 278873 | 1% | 72% | 13 | Search DP2 | Search DP2 |
10 | L PGDS | 253112 | 1% | 61% | 14 | Search L+PGDS | Search L+PGDS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |